9 METERS BIOPHARMA INC (NMTR) Earnings History & Surprises

NASDAQ:NMTR • US6544052086

0.0722 USD
-0.05 (-42.97%)
At close: Jul 25, 2023
0.093 USD
+0.02 (+28.81%)
After Hours: 7/25/2023, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

Past quarterly earnings results for 9 METERS BIOPHARMA INC (NMTR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateAug 14, 2023
PeriodQ2 / 2023
EPS Estimate-$0.59
Revenue Estimate

Last Reported

Most Recent
Release DateMay 15, 2023
PeriodQ1 / 2023
EPS Reported-$1.02
EPS Surprise -28.53%
Revenue Surprise %

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2023 -1.02 -0.79 -28.53% -27.50% - -
Q4 2022 -0.92 -0.78 -18.34% -15.00% - -
Q3 2022 -0.72 -0.84 13.92% 28.00% - -
Q2 2022 -0.80 -0.85 5.89% -33.33% - -
Q1 2022 -0.80 -0.77 -4.58% -33.33% - -
Q4 2021 -0.80 -0.73 -8.93% 20.00% - -
Q3 2021 -1.00 -0.75 -33.68% 16.67% - -
Q2 2021 -0.60 -0.61 1.96% - - -
Q1 2021 -0.60 -0.56 -6.95% - - -
Q4 2020 -1.00 -0.84 -18.84% - - -
Q3 2020 -1.20 -1.22 1.96% - - -
Q2 2020 - - - -
Q1 2020 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

NMTR EPS Q2Q GrowthNMTR EPS Q2Q GrowthEPS Q2Q Growth Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 0 -50 -100 -150

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-6.77%
Max EPS beat (4)
13.92%
Min EPS beat (4)
-28.53%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, NMTR has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, NMTR reported -6.8% below the EPS estimates on average.

Related analysis

NMTR Overview NMTR Technical Analysis Report NMTR Fundamental Analysis Report NMTR Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

9 METERS BIOPHARMA INC / NMTR Earnings FAQ

When did 9 METERS BIOPHARMA INC (NMTR) report earnings last quarter?

9 METERS BIOPHARMA INC (NMTR) last reported earnings on 5/15/2023.


Did 9 METERS BIOPHARMA INC (NMTR) beat earnings estimates last quarter?

9 METERS BIOPHARMA INC (NMTR) missed EPS estimates and missed revenue estimates in the most recent quarter.


Can you provide information on how often 9 METERS BIOPHARMA INC beats earnings estimates?

In the last 4 quarters, 9 METERS BIOPHARMA INC (NMTR) has beaten EPS estimates in 2 out of 4 releases.